Long-Acting Schizophrenia Drug Market – Extended-Release Therapies Improving Treatment Adherence
Market Overview The long-acting schizophrenia drug market is expanding as psychiatric care increasingly emphasizes treatment adherence as a critical factor in relapse prevention and long-term patient stability. These formulations, administered via injection at extended intervals, reduce the burden of daily oral medication compliance common among schizophrenia patients. The Long Acting...
0 Commentarios 0 Acciones 408 Views 0 Vista previa
SocioMint https://sociomint.com